These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34149679)

  • 21. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
    Yan L; Cai B; Li Y; Wang MJ; An YF; Deng R; Li DD; Wang LC; Xu H; Gao XD; Wang LL
    J Cell Mol Med; 2020 Dec; 24(24):14270-14279. PubMed ID: 33145962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of Tα1 on the infective patients after hematopoietic stem cell transplantation.
    Ding JH; Wang LL; Chen Z; Wang J; Yu ZP; Zhao G; Chen BA
    Int J Hematol; 2013 Feb; 97(2):280-3. PubMed ID: 23307511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of thymosin α1 on mortality of critical COVID-19 patients: A multicenter retrospective study.
    Sun Q; Xie J; Zheng R; Li X; Chen H; Tong Z; Du B; Qiu H; Yang Y
    Int Immunopharmacol; 2021 Jan; 90():107143. PubMed ID: 33208294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune modulation via dendritic cells by the effect of Thymosin-alpha-1 on immune synapse in HCMV infection.
    Espinar-Buitrago MS; Vazquez-Alejo E; Magro-Lopez E; Tarancon-Diez L; Leal M; Muñoz-Fernandez MA
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111103. PubMed ID: 38149577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific dynamic variations in the peripheral blood lymphocyte subsets in COVID-19 and severe influenza A patients: a retrospective observational study.
    Qian F; Gao G; Song Y; Xu Y; Wang A; Wang S; Hao Y; Chen M; Ma X; Zhao T; Guo X; Chen Z; Zhang F
    BMC Infect Dis; 2020 Dec; 20(1):910. PubMed ID: 33261583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study.
    Wu M; Ji JJ; Zhong L; Shao ZY; Xie QF; Liu ZY; Wang CL; Su L; Feng YW; Liu ZF; Yao YM
    Int Immunopharmacol; 2020 Nov; 88():106873. PubMed ID: 32795897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zoledronic acid and thymosin α1 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells.
    Wang S; Huang M; Chen M; Sun Z; Jiao Y; Ye G; Pan J; Ye W; Zhao J; Zhang D
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37295817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of a novel long-acting thymosin alpha1-Fc fusion protein and its efficacy for the inhibition of breast cancer in vivo.
    Shen X; Li Q; Wang F; Bao J; Dai M; Zheng H; Lao X
    Biomed Pharmacother; 2018 Dec; 108():610-617. PubMed ID: 30243095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2-reactive IFN-γ-producing CD4
    Olea B; Albert E; Giménez E; Torres I; Amat P; Remigia MJ; Alberola J; Carbonell N; Ferreres J; Blasco ML; Navarro D
    Sci Rep; 2022 Aug; 12(1):14271. PubMed ID: 35995830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of thymosin alpha-1 on subpopulations of Th1, Th2, Th17, and regulatory T cells (Tregs) in vitro.
    Yang X; Qian F; He HY; Liu KJ; Lan YZ; Ni B; Tian Y; Fu XL; Zhang J; Shen ZG; Li J; Yin Y; Li JT; Wu YZ
    Braz J Med Biol Res; 2012 Jan; 45(1):25-32. PubMed ID: 22245858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exhausting T Cells During HIV Infection May Improve the Prognosis of Patients with COVID-19.
    Lin HS; Lin XH; Wang JW; Wen DN; Xiang J; Fan YQ; Li HD; Wu J; Lin Y; Lin YL; Sun XR; Chen YF; Chen CJ; Lian NF; Xie HS; Lin SH; Xie QF; Li CW; Peng FZ; Wang N; Lin JQ; Chen WJ; Huang CL; Fu Y
    Front Cell Infect Microbiol; 2021; 11():564938. PubMed ID: 34646783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of peripheral lymphocyte subsets and T-cell exhaustion in SARS-CoV-2 Infection.
    Soyyiğit Ş; Öksüzer Çimşir D; Öncül A; Pekel A; Öner Erkekol F; Güner R; İzdeş S; Gökmen D; Gökbulut Bektaş Ş; İnan O; Gemcioğlu E; Yılmaz A; Şahiner ES; Hasanoğlu İ; Kaya Kalem A; Kayaaslan B; Eser F; Ateş İ
    Tuberk Toraks; 2024 Jun; 72(2):152-166. PubMed ID: 38869208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel evidence of Thymosin α1 immunomodulatory properties in SARS-CoV-2 infection: Effect on innate inflammatory response in a peripheral blood mononuclear cell-based in vitro model.
    Ricci D; Etna MP; Severa M; Fiore S; Rizzo F; Iannetta M; Andreoni M; Balducci S; Stefanelli P; Palamara AT; Coccia EM
    Int Immunopharmacol; 2023 Apr; 117():109996. PubMed ID: 36933449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulatory function of orally administered thymosin alpha1.
    Chen XM; Jiang HL; Zhou LF; Pan XP; Hu ZR; Liu RH; Chen XM; Chen Z
    J Zhejiang Univ Sci B; 2005 Sep; 6(9):873-6. PubMed ID: 16130188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial.
    Wu J; Zhou L; Liu J; Ma G; Kou Q; He Z; Chen J; Ou-Yang B; Chen M; Li Y; Wu X; Gu B; Chen L; Zou Z; Qiang X; Chen Y; Lin A; Zhang G; Guan X
    Crit Care; 2013 Jan; 17(1):R8. PubMed ID: 23327199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study of thymosin alpha1 therapy for chronic hepatitis B patients.
    Arase Y; Tsubota A; Suzuki Y; Suzuki F; Kobayashi M; Someya T; Akuta N; Hosaka T; Saitoh S; Ikeda K; Kobayashi M; Kumada H
    Intern Med; 2003 Oct; 42(10):941-6. PubMed ID: 14606705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of thymosin alpha 1 combined with multi-modality chemotherapy and its effects on immune function of patients with pulmonary tuberculosis complicated with diabetes.
    Wu L; Luo PP; Tian YH; Chen LY; Zhang YL
    Pak J Med Sci; 2022; 38(1):179-184. PubMed ID: 35035422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19.
    Liu Y; Liao W; Wan L; Xiang T; Zhang W
    Viral Immunol; 2021 Jun; 34(5):330-335. PubMed ID: 32297828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymosin alpha 1 treatment for patients with sepsis.
    Pei F; Guan X; Wu J
    Expert Opin Biol Ther; 2018 Jul; 18(sup1):71-76. PubMed ID: 30063866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymosin alpha 1: from bench to bedside.
    Garaci E; Favalli C; Pica F; Sinibaldi Vallebona P; Palamara AT; Matteucci C; Pierimarchi P; Serafino A; Mastino A; Bistoni F; Romani L; Rasi G
    Ann N Y Acad Sci; 2007 Sep; 1112():225-34. PubMed ID: 17600290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.